Nephros to Present at the Q1 Virtual Investor Summit
03/16/2021 - 07:45 AM
SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Q1 Virtual Investor Summit. The conference will take place on March 23-25, 2021, and includes a Nephros company presentation and Q&A at 2:30 p.m. ET on March 23.
To register to attend the live presentation click the following link:
https://zoom.us/webinar/register/WN_rBYVMLR8RP6-JbQsQa1qOQ
To request a complimentary investor registration and 1-to-1 meeting with Nephros, please visit the conference website at www.investorsummitgroup.com .
About Nephros
Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Our diverse team of passionate employees are dedicated to advancing point-of-use water safety through education, product solutions, and emergency outbreak response management.
For more information about Nephros, please visit www.nephros.com .
About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting small-cap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.
Conference Contact: brittney@investorsummitgroup.com
Investor Relations Contact: ksmith@pcgadvisory.com www.pcgadvisory.com
Company Contact: andy@nephros.com www.nephros.com
Wire Service Contact www.InvestorWire.com Editor@InvestorWire.com
NEPH Rankings
#361 Ranked by Stock Gains
NEPH Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Medical Specialties, Health Technology, Manufacturing, Surgical and Medical Instrument Manufacturing
About NEPH
nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil
